QA: Gain Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001819411_2023_Gain_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001819411, Gain Therapeutics Inc.

  xvar xval
0 AssetsCurrent 21,091,296
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 144,379
3 remainder_Assets 2,863,712
4 LiabilitiesCurrent 4,125,251
5 LiabilitiesNoncurrent 1,094,622
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,539,863
9 ResearchAndDevelopmentExpense 8,377,290
10 remainder_Expenses 92,976
11 remainder_Revenues 140,108
12 remainder_NetIncome 279,283
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 24,099,387
1 Liabilities 5,219,873
2 Expenses 18,010,129
3 Revenues 140,108
4 StockholdersEquity 18,879,514
5 NetIncome -17,590,738
6 ComprehensiveNetIncome -17,590,738
7 BaseVar 23,874,390
8 EconomicCapitalRatio 1.02

Edgar->Model Mapping

Feature Distribution

Change over Time